Bone Mineral Density in Patients with Inflammatory Bowel Disease: A Population-Based Prospective Two-Year Follow-Up Study

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 2, 2004, Pages 145-153

  Jahnsen, J ^a   Falch, J A ^b   Mowinckel, P ^b   Aadland, E ^b  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

Bone mineral density; Crohn disease; Inflammatory bowel disease; Osteoporosis; Ulcerative colitis

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CALCITRIOL; CALCIUM; CORTICOSTEROID; HEMOGLOBIN; OSTEOCALCIN; PARATHYROID HORMONE; PYRIDINOLINE;

ABSORPTIOMETRY; ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CHEMICAL ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; CROHN DISEASE; ENTERITIS; EVALUATION; FEMALE; FEMUR NECK; FOLLOW UP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OSTEOLYSIS; PATHOGENESIS; PATIENT; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; ULCERATIVE COLITIS; X RAY ANALYSIS;

ADRENAL CORTEX HORMONES; ADULT; AGED; BODY MASS INDEX; BONE DENSITY; COLITIS, ULCERATIVE; CROHN DISEASE; DENSITOMETRY, X-RAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PROSPECTIVE STUDIES;

EID: 1342267486     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520310007873     Document Type: Article

References (41)

1. Andreassen H, Rungby J, Dahlerup JF, Mosekilde L. Inflammatory bowel disease and osteoporosis. Scand J Gastroenterol 1997;32:1247-55.
2. Compston JE. Osteoporosis, corticosteroids and inflammatory bowel disease [review article]. Aliment Pharmacol Ther 1995;9:237-50.
3. Schoon EJ, Wolffenbuttel BHR, Stockbrugger RW. Osteoporosis as a risk in inflammatory bowel disease. Drugs Today 1999;35:17-28.
4. Cino M, Greenberg GR. Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy. Am J Gastroenterol 2002;97:915-21.
5. Clements D, Motley RJ, Evans WD, Harries AD, Rhodes J, Coles RJ, et al. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol 1992;27:1055-60.
6. Ulivieri FM, Piodi LP, Taioli E, Lisciandrano D, Ranzi T, Vezzoli M, et al. Bone mineral density and body composition in ulcerative colitis: a six-year follow-up. Osteoporos Int 2001;12:343-8.
7. Klaus J, Armbrecht G, Steinkamp M, Bruckel J, Rieber A, Adler G, et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut 2002;51:654-8.
8. Stockbrugger RW, Schoon EJ, Bollani S, Mills PR, Israeli E, Landgraf L, et al. Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther 2002;16:1519-27.
9. Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population-based study. Gut 1997;40:313-9.
10. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 2002;37:192-9.
11. Falch JA, Meyer HE. Bone mineral density measured by dual X-ray absorptiometry. Reference values in a Norwegian population. Tidsskr Nor Laegefor 1996;116:2299-302.
12. Motley RJ, Crawley EO, Evans C, Rhodes J, Compston JE. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut 1988;29:1332-6.
13. Motley RJ, Clements D, Evans WD, Crawley EO, Evans C, Rhodes J, et al. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner 1993;23:95-104.
14. Staun M, Tjellesen L, Thale M, Schaadt O, Jarnum S. Bone mineral content in patients with Crohn's disease. A longitudinal study in patients with bowel resections. Scand J Gastroenterol 1997;32:226-32.
15. Roux C, Abitbol V, Chaussade S, Kolta S, Guillemant S, Dougados M, et al. Bone loss in patients with inflammatory bowel disease: a prospective study. Osteoporos Int 1995;5:156-60.
16. Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994;107:1031-9.
17. Schoon EJ, Bollani S, Mills P, Israeli E, Felsenberg D, Ljunghall S, et al. Budesonide versus prednisolone: effect on bone mineral density in patients with ileo-cecal Crohn's disease. Gut 2002;51:A48.
18. Bischoff SC, Herrmann A, Goke M, Manns MP, von zur Muhlen A, Brabant G. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 1997;92:1157-63.
19. Robinson RJ, Iqbal SJ, Abrams K, Al-Azzawi F, Mayberry JF. Increased bone resorption in patients with Crohn's disease. Aliment Pharmacol Ther 1998;12:699-705.
20. Schoon EJ, Geerling BG, Van Dooren IM, Schurgers LJ, Vermeer C, Brummer RJ, et al. Abnormal bone turnover in long-standing Crohn's disease in remission. Aliment Pharmacol Ther 2001;15:783-92.
21. Dinca M, Fries W, Luisetto G, Peccolo F, Bottega F, Leone L, et al. Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol 1999;94:1292-7.
22. Schulte C, Dignass AU, Mann K, Goebell H. Bone loss in patients with inflammatory bowel disease is less than expected: a follow-up study. Scand J Gastroenterol 1999;34:696-702.
23. Dresner-Pollak R, Karmeli F, Eliakim R, Ackerman Z, Rachmilewitz D. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. Am J Gastroenterol 2000;95:699-704.
24. Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol 1995;7:609-14.
25. von Tirpitz C, Klaus J, Bruckel J, Rieber A, Scholer A, Adler G, et al. Increase of bone mineral density with sodium fluoride in patients with Crohn's disease. Eur J Gastroenterol Hepatol 2000;12:19-24.
26. Abitbol V, Mary JY, Roux C, Soule JC, Belaiche J, Dupas JL, et al. Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride. Aliment Pharmacol Ther 2002;16:919-27.
27. Haderslev KV, Tjellesen L, Sorensen HA, Staun M. Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease. Gastroenterology 2000;119:639-46.
28. Clements D, Compston JE, Evans WD, Rhodes J. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut 1993;34:1543-6.
29. Robinson RJ, Krzywicki T, Almond L, al-Azzawi F, Abrams K, Iqbal SJ, et al. Effect of a low-impact exercise program on bone mineral density in Crohn's disease: a randomized controlled trial. Gastroenterology 1998;115:36-41.
30. Driscoll RH, Jr, Meredith SC, Sitrin M, Rosenberg IH, Vitamin D. deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982;83:1252-8.
31. Lamb EJ, Wong T, Smith DJ, Simpson DE, Coakley AJ, Moniz C, et al. Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2002;16:1895-902.
32. Silvennoinen J. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J Intern Med 1996;239:131-7.
33. Andreassen H, Rix M, Brot C, Eskildsen P. Regulators of calcium homeostasis and bone mineral density in patients with Crohn's disease. Scand J Gastroenterol 1998;33:1087-93.
34. Cowan FJ, Parker DR, Jenkins HR. Osteopenia in Crohn's disease. Arch Dis Child 1995;73:255-6.
35. Semeao EJ, Stallings VA, Peck SN, Piccoli DA. Vertebral compression fractures in pediatric patients with Crohn's disease. Gastroenterology 1997;112:1710-3.
36. Thearle M, Horlick M, Bilezikian JP, Levy J, Gertner JM, Levine LS, et al. Osteoporosis: an unusual presentation of childhood Crohn's disease. J Clin Endocrinol Metab 2000;85:2122-6.
37. Courtney AC, Wachtel EF, Myers ER, Hayes WC. Effects of loading rate on strength of the proximal femur. Calcif Tissue Int 1994;55:53-8.
38. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 1996;312:1254-9.
39. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Ultrasound measurements of calcaneus for estimation of skeletal status in patients with inflammatory bowel disease. Scand J Gastroenterol 1999;34:790-7.
40. Scott EM, Gaywood I, Scott BB. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut 2000;46 Suppl 1:i1-8.
41. Valentine JF, Sninsky CA. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease. Am J Gastroenterol 1999;94:878-83.